Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec;37(6):1020-1049.
doi: 10.1111/fcp.12924. Epub 2023 Jun 26.

KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury

Leonid N Maslov  1 , Sergey V Popov  1 , Natalia V Naryzhnaya  1 , Alexandr V Mukhomedzyanov  1 , Boris K Kurbatov  1 , Ivan A Derkachev  1 , Alla A Boshchenko  1 , N Rajendra Prasad  2 , Huijie Ma  3 , Yi Zhang  3 , Galina Z Sufianova  4 , Feng Fu  5 , Jian-Ming Pei  5
Affiliations
Review

KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury

Leonid N Maslov et al. Fundam Clin Pharmacol. 2023 Dec.

Abstract

Background: The use of percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) is associated with a mortality rate of 5%-7%. It is clear that there is an urgent need to develop new drugs that can effectively prevent cardiac reperfusion injury. ATP-sensitive K+ (KATP ) channel openers (KCOs) can be classified as such drugs.

Results: KCOs prevent irreversible ischemia and reperfusion injury of the heart. KATP channel opening promotes inhibition of apoptosis, necroptosis, pyroptosis, and stimulation of autophagy. KCOs prevent the development of cardiac adverse remodeling and improve cardiac contractility in reperfusion. KCOs exhibit antiarrhythmic properties and prevent the appearance of the no-reflow phenomenon in animals with coronary artery occlusion and reperfusion. Diabetes mellitus and a cholesterol-enriched diet abolish the cardioprotective effect of KCOs. Nicorandil, a KCO, attenuates major adverse cardiovascular event and the no-reflow phenomenon, reduces infarct size, and decreases the incidence of ventricular arrhythmias in patients with acute myocardial infarction.

Conclusion: The cardioprotective effect of KCOs is mediated by the opening of mitochondrial KATP (mitoKATP ) and sarcolemmal KATP (sarcKATP ) channels, triggered free radicals' production, and kinase activation.

Keywords: KATP channels; cardiac remodeling; heart; microvascular obstruction; programmed cell death; reperfusion.

PubMed Disclaimer

References

REFERENCES

    1. Fabris E, Kilic S, Schellings DAAM, et al. Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction. Heart. 2017;103(19):1515-1520. doi:10.1136/heartjnl-2017-311181
    1. Menees DS, Peterson ED, Wang Y, et al. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 2013;369(10):901-909. doi:10.1056/NEJMoa1208200
    1. Olier I, Sirker A, Hildick-Smith DJR, et al. Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention. Heart. 2018;104(20):1683-1690. doi:10.1136/heartjnl-2017-312366
    1. Gong X, Ding X, Chen H, Li H. Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/beta-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-up. J Transl Med. 2018;16(1):346. doi:10.1186/s12967-018-1720-3
    1. Ndrepepa G. Improving myocardial injury, infarct size, and myocardial salvage in the era of primary PCI for STEMI. Coron Artery Dis. 2015;26(4):341-355. doi:10.1097/MCA.0000000000000220

LinkOut - more resources